Comprehensive exploration of the genetic contribution of the dopaminergic and serotonergic pathways to psychiatric disorders.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
10 01 2022
Historique:
received: 07 01 2021
accepted: 13 10 2021
revised: 08 09 2021
entrez: 11 1 2022
pubmed: 12 1 2022
medline: 1 2 2022
Statut: epublish

Résumé

Psychiatric disorders are highly prevalent and display considerable clinical and genetic overlap. Dopaminergic and serotonergic neurotransmission have been shown to play an important role in many psychiatric disorders. Here we aim to assess the genetic contribution of these systems to eight psychiatric disorders (attention-deficit hyperactivity disorder (ADHD), anorexia nervosa (ANO), autism spectrum disorder (ASD), bipolar disorder (BIP), major depression (MD), obsessive-compulsive disorder (OCD), schizophrenia (SCZ) and Tourette's syndrome (TS)) using publicly available GWAS analyses performed by the Psychiatric Genomics Consortium that include more than 160,000 cases and 275,000 controls. To do so, we elaborated four different gene sets: two 'wide' selections for dopamine (DA) and for serotonin (SERT) using the Gene Ontology and KEGG pathways tools, and two'core' selections for the same systems, manually curated. At the gene level, we found 67 genes from the DA and/or SERT gene sets significantly associated with one of the studied disorders, and 12 of them were associated with two different disorders. Gene-set analysis revealed significant associations for ADHD and ASD with the wide DA gene set, for BIP with the wide SERT gene set, and for MD with the core SERT set. Interestingly, interrogation of a cross-disorder GWAS meta-analysis of the eight psychiatric conditions displayed association with the wide DA gene set. To our knowledge, this is the first systematic examination of genes encoding proteins essential to the function of these two neurotransmitter systems in these disorders. Our results support a pleiotropic contribution of the dopaminergic and serotonergic systems in several psychiatric conditions.

Identifiants

pubmed: 35013130
doi: 10.1038/s41398-021-01771-3
pii: 10.1038/s41398-021-01771-3
pmc: PMC8748838
doi:

Substances chimiques

Dopamine VTD58H1Z2X

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11

Informations de copyright

© 2021. The Author(s).

Références

Eur Neuropsychopharmacol. 2015 Dec;25(12):2318-25
pubmed: 26527055
Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
Nat Commun. 2018 May 8;9(1):1825
pubmed: 29739930
Br J Psychiatry. 1967 Nov;113(504):1237-64
pubmed: 4169954
Cold Spring Harb Perspect Med. 2012 Dec 01;2(12):a009621
pubmed: 23071379
Clin Psychopharmacol Neurosci. 2014 Dec;12(3):196-202
pubmed: 25598822
Behav Brain Funct. 2012 May 04;8:19
pubmed: 22559203
Ann Pharmacother. 2014 Feb;48(2):209-25
pubmed: 24259638
Diabetes Care. 2018 Apr;41(4):770-774
pubmed: 29374069
Science. 2018 Jun 22;360(6395):
pubmed: 29930110
Neurochem Int. 2015 Mar;82:52-68
pubmed: 25684070
Nat Genet. 2019 Mar;51(3):431-444
pubmed: 30804558
Expert Rev Neurother. 2016;16(3):279-93
pubmed: 26807870
Cell. 2019 Dec 12;179(7):1469-1482.e11
pubmed: 31835028
Am J Hum Genet. 2006 Oct;79(4):614-27
pubmed: 16960798
Soc Psychiatry Psychiatr Epidemiol. 1998 Dec;33(12):587-95
pubmed: 9857791
Philos Trans R Soc Lond B Biol Sci. 2013 Feb 25;368(1615):20120535
pubmed: 23440469
Neuropsychiatr Dis Treat. 2016 Dec 09;12:3129-3144
pubmed: 28003749
Eat Weight Disord. 2007 Jun;12(2):91-6
pubmed: 17615493
Psychiatr Genet. 2019 Oct;29(5):142-151
pubmed: 31464995
Nat Genet. 2015 Jul;47(7):702-9
pubmed: 25985137
Nat Genet. 2018 Jul;50(7):920-927
pubmed: 29942085
Nat Genet. 2018 May;50(5):668-681
pubmed: 29700475
Nat Genet. 2019 Jan;51(1):63-75
pubmed: 30478444
Clin Genet. 2004 Nov;66(5):382-92
pubmed: 15479180
Res Dev Disabil. 2014 Jul;35(7):1658-65
pubmed: 24780147
F1000Res. 2017 Feb 23;6:180
pubmed: 28299200
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Curr Med Sci. 2018 Jun;38(3):538-551
pubmed: 30074224
Neuroimage Clin. 2019;23:101928
pubmed: 31491815
Indian J Psychiatry. 2011 Oct;53(4):289-99
pubmed: 22303036
Am J Psychiatry. 2019 Mar 1;176(3):217-227
pubmed: 30818990
Neurosci Biobehav Rev. 2017 Sep;80:372-381
pubmed: 28576508
Br J Psychiatry. 2002 Oct;181:306-14
pubmed: 12356657
Lancet. 2018 Apr 7;391(10128):1357-1366
pubmed: 29477251
Mol Psychiatry. 2018 May;23(5):1181-1188
pubmed: 28761083
Med Sci Monit. 2011 Sep;17(9):RA215-20
pubmed: 21873960
Curr Top Med Chem. 2016;16(29):3385-3403
pubmed: 27291902
Hum Genet. 2009 Jul;126(1):51-90
pubmed: 19506906
Am J Med Genet B Neuropsychiatr Genet. 2018 Mar;177(2):211-231
pubmed: 28766921
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
Am J Psychiatry. 2017 Sep 1;174(9):850-858
pubmed: 28494655
JAMA Psychiatry. 2019 Mar 1;76(3):259-270
pubmed: 30649197
Psychol Med. 2018 Aug;48(11):1759-1774
pubmed: 29198204
Schizophr Bull. 2015 Sep;41(5):1171-82
pubmed: 25829376
J Am Acad Child Adolesc Psychiatry. 2017 Mar;56(3):234-240.e1
pubmed: 28219489
Cell. 2017 Jun 15;169(7):1177-1186
pubmed: 28622505
Neurosci Biobehav Rev. 2013 Jul;37(6):1026-39
pubmed: 23333760
Mol Psychiatry. 2019 Apr;24(4):562-575
pubmed: 29892054
Bioinformatics. 2010 Sep 1;26(17):2190-1
pubmed: 20616382
Nat Genet. 2018 Mar;50(3):381-389
pubmed: 29483656
Neuropharmacology. 2009 Dec;57(7-8):579-89
pubmed: 19627998
Nature. 2015 Mar 12;519(7542):223-8
pubmed: 25533962
Int J Epidemiol. 2014 Apr;43(2):476-93
pubmed: 24648481
Am J Hum Genet. 2014 Oct 2;95(4):360-70
pubmed: 25262651
Nat Neurosci. 2019 Mar;22(3):343-352
pubmed: 30718901
Diabetes Care. 2018 Dec;41(12):2502-2508
pubmed: 30373735
Schizophr Bull. 2018 Aug 20;44(5):958-965
pubmed: 29982775
J Neurol Neurosurg Psychiatry. 2002 Jan;72(1):12-21
pubmed: 11784818
J Psychiatr Res. 2015 Jan;60:1-13
pubmed: 25287955
Nat Genet. 2019 May;51(5):793-803
pubmed: 31043756
Prog Neurobiol. 2015 Nov;134:36-54
pubmed: 26386135
Cell. 2004 Oct 1;119(1):19-31
pubmed: 15454078
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Mol Psychiatry. 2013 Dec;18(12):1315-23
pubmed: 23979605
Psychiatry Clin Neurosci. 2019 Jun;73(6):289-301
pubmed: 30734985
Psychiatry Res. 2018 Jul;265:25-38
pubmed: 29680514
Schizophr Bull. 2007 Sep;33(5):1071-81
pubmed: 17630406
Nat Genet. 2019 Mar;51(3):445-451
pubmed: 30643256
Front Hum Neurosci. 2015 Oct 12;9:561
pubmed: 26528167

Auteurs

Judit Cabana-Domínguez (J)

Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Universitat de Barcelona, Barcelona, Catalonia, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain.
Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, Catalonia, Spain.
Institut de Recerca Sant Joan de Déu (IR-SJD), Esplugues de Llobregat, Barcelona, Catalonia, Spain.

Bàrbara Torrico (B)

Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Universitat de Barcelona, Barcelona, Catalonia, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain.
Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, Catalonia, Spain.
Institut de Recerca Sant Joan de Déu (IR-SJD), Esplugues de Llobregat, Barcelona, Catalonia, Spain.

Andreas Reif (A)

Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main, Germany.

Noèlia Fernàndez-Castillo (N)

Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Universitat de Barcelona, Barcelona, Catalonia, Spain. noefernandez@ub.edu.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain. noefernandez@ub.edu.
Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, Catalonia, Spain. noefernandez@ub.edu.
Institut de Recerca Sant Joan de Déu (IR-SJD), Esplugues de Llobregat, Barcelona, Catalonia, Spain. noefernandez@ub.edu.

Bru Cormand (B)

Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Universitat de Barcelona, Barcelona, Catalonia, Spain. bcormand@ub.edu.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain. bcormand@ub.edu.
Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, Catalonia, Spain. bcormand@ub.edu.
Institut de Recerca Sant Joan de Déu (IR-SJD), Esplugues de Llobregat, Barcelona, Catalonia, Spain. bcormand@ub.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH